3/27
12:02 pm
kod
Kodiak Sciences: Shares Up On Positive Eye Disease Data - But I Remain On Sidelines [Seeking Alpha]
Low
Report
Kodiak Sciences: Shares Up On Positive Eye Disease Data - But I Remain On Sidelines [Seeking Alpha]
3/27
11:52 am
kod
Kodiak Sciences (KOD) had its price target raised by UBS Group AG from $50.00 to $80.00. They now have a "buy" rating on the stock.
High
Report
Kodiak Sciences (KOD) had its price target raised by UBS Group AG from $50.00 to $80.00. They now have a "buy" rating on the stock.
3/27
08:02 am
kod
Kodiak Sciences (KOD) had its "buy" rating reaffirmed by HC Wainwright. They now have a $58.00 price target on the stock, up from $38.00.
Medium
Report
Kodiak Sciences (KOD) had its "buy" rating reaffirmed by HC Wainwright. They now have a $58.00 price target on the stock, up from $38.00.
3/26
11:40 pm
kod
Kodiak Sciences (KOD) CLimbs 75% on Stellar Clinical Results [Yahoo! Finance]
Medium
Report
Kodiak Sciences (KOD) CLimbs 75% on Stellar Clinical Results [Yahoo! Finance]
3/26
06:26 am
kod
Kodiak Sciences Announces Positive Topline Results in GLOW2, the Second Phase 3 Study in Diabetic Retinopathy, Demonstrating Superiority of Zenkuda™ (tarcocimab tedromer) Over Sham [Yahoo! Finance]
High
Report
Kodiak Sciences Announces Positive Topline Results in GLOW2, the Second Phase 3 Study in Diabetic Retinopathy, Demonstrating Superiority of Zenkuda™ (tarcocimab tedromer) Over Sham [Yahoo! Finance]
3/26
06:00 am
kod
Kodiak Sciences Announces Positive Topline Results in GLOW2, the Second Phase 3 Study in Diabetic Retinopathy, Demonstrating Superiority of Zenkuda™ (tarcocimab tedromer) Over Sham
High
Report
Kodiak Sciences Announces Positive Topline Results in GLOW2, the Second Phase 3 Study in Diabetic Retinopathy, Demonstrating Superiority of Zenkuda™ (tarcocimab tedromer) Over Sham
3/14
07:22 pm
kod
Assessing Kodiak Sciences (KOD) Valuation After Recent Share Price Weakness And Strong One Year Return [Yahoo! Finance]
Low
Report
Assessing Kodiak Sciences (KOD) Valuation After Recent Share Price Weakness And Strong One Year Return [Yahoo! Finance]
3/9
10:19 am
kod
Investment Firm Doubles Down on Biotech Stock, Adds 386,000 Shares, According to Recent SEC Filing [Yahoo! Finance]
Medium
Report
Investment Firm Doubles Down on Biotech Stock, Adds 386,000 Shares, According to Recent SEC Filing [Yahoo! Finance]
2/24
06:33 am
kod
A Look At Kodiak Sciences (KOD) Valuation After Its Strong One Year Shareholder Return [Yahoo! Finance]
Medium
Report
A Look At Kodiak Sciences (KOD) Valuation After Its Strong One Year Shareholder Return [Yahoo! Finance]
2/10
08:05 am
kod
Kodiak Sciences (NASDAQ:KOD) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.
Medium
Report
Kodiak Sciences (NASDAQ:KOD) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.
2/4
07:22 am
kod
Final APEX Phase 1b Clinical Results for Kodiak's KSI-101 in Macular Edema Secondary to Inflammation to be Presented at Angiogenesis 2026 [Yahoo! Finance]
Medium
Report
Final APEX Phase 1b Clinical Results for Kodiak's KSI-101 in Macular Edema Secondary to Inflammation to be Presented at Angiogenesis 2026 [Yahoo! Finance]
2/4
07:00 am
kod
Final APEX Phase 1b Clinical Results for Kodiak's KSI-101 in Macular Edema Secondary to Inflammation to be Presented at Angiogenesis 2026
Medium
Report
Final APEX Phase 1b Clinical Results for Kodiak's KSI-101 in Macular Edema Secondary to Inflammation to be Presented at Angiogenesis 2026
2/3
08:00 am
kod
Kodiak Sciences: A Stellar Move [Seeking Alpha]
Low
Report
Kodiak Sciences: A Stellar Move [Seeking Alpha]
1/22
07:19 am
kod
Kodiak Sciences (NASDAQ:KOD) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Low
Report
Kodiak Sciences (NASDAQ:KOD) had its "buy" rating reaffirmed by analysts at HC Wainwright.
1/12
07:26 am
kod
3 Small-Cap Blend Mutual Funds With Strong Growth Potential [Yahoo! Finance]
Medium
Report
3 Small-Cap Blend Mutual Funds With Strong Growth Potential [Yahoo! Finance]
1/11
11:41 am
kod
Is It Too Late To Consider Kodiak Sciences (KOD) After Its 233% One-Year Surge? [Yahoo! Finance]
Low
Report
Is It Too Late To Consider Kodiak Sciences (KOD) After Its 233% One-Year Surge? [Yahoo! Finance]
1/9
06:10 am
kod
Kodiak Sciences (NASDAQ:KOD) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
Medium
Report
Kodiak Sciences (NASDAQ:KOD) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
1/7
09:12 pm
kod
Kodiak Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Low
Report
Kodiak Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
1/7
08:19 pm
kod
Kodiak Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference
Low
Report
Kodiak Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference
1/7
02:01 am
kod
Kodiak Sciences (NASDAQ:KOD) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.
Medium
Report
Kodiak Sciences (NASDAQ:KOD) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.